GlassScriptPhysician profile
Omair M Ali
NPI 1962639864
$3,132.24
in general payments reported to CMS, 2019-2025
20 companies · $566 in 2025
The $566 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $240 · 2021: $125 · 2022: $543 · 2023: $755 · 2024: $645 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,966.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,385.57 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console, Cardiomems |
| Actelion Pharmaceuticals US, INC. | $347.78 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| United Therapeutics Corporation | $324.13 | 2023-2025 | Remodulin |
| Abiomed | $209.62 | 2022 | |
| Kestra Medical Technology Services, INC. | $189.62 | 2022-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $147.36 | 2024 | Winrevair |
| Solventum Corporation | $87.44 | 2024 | Abthera, Prevena, V.A.C. Veraflo |
| Inari Medical, INC. | $62.72 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.65 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $51.16 | 2020 | |
| Novartis Pharmaceuticals Corporation | $44.93 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $36.65 | 2023 | Camzyos |
| Pfizer INC. | $33.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.39 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.92 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $24.99 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Amgen INC. | $22.38 | 2025 | Repatha |
| Scpharmaceuticals INC. | $19.99 | 2023 | |
| Terumo Medical Corporation | $16.37 | 2025 | Glidewire, Angio-Seal |
| Alnylam Pharmaceuticals INC. | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omair Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.